Flora Growth’s New Columbian Lab to Hunt Cannabis’ Health Secrets

Flora Growth (NASDAQ: FLGC) announced this week the completion of its new research laboratory in Bogota, Columbia. The Toronto-based cultivation giant says its lab in Columbia will serve as the company’s hub of discovery, development, manufacturing and commercialization of phytocannabinoid-based prescription medicines and nutraceutical products to address a broad range of ailments and diseases.

“The completion of Flora Lab 4 is an important step in Flora Growth’s progress toward commercializing medicinal cannabis. This lab is built to produce prescription grade medications and manufacture cannabis-based formulations,” said Luis Merchan, chairman and CEO of Flora Growth Corp. “We look forward to giving access to prescribing doctors in Colombia and more importantly, to patients who stand to benefit from safe, high quality medicinal cannabis.”

Flora Lab 4 will specialize in the manufacturing of compound formulations utilizing cannabis derivatives and traditional master formulas. The facility will offer design, development and manufacturing services of master formulas for third parties, making available to clients its knowledge of cannabis, its professional team and modern facilities to promote growth in the sector.

The research facility is part of Flora’s group of laboratories that produce cosmetics, phytotherapeutic products, dietary supplements and cannabis extraction and transformation.

Flora Lab 4’s initial prescription formulations have been developed to support the treatment of specific ailments such as social anxiety and acne. The laboratory is waiting for a regulatory inspection by Colombia National Food and Drug Surveillance Institute to complete certification. Once this step is complete, the new formulations will be available to prescribing doctors in Colombia.